Inclusion criteria were: suspicion of endometrial hyperplasia and endometrial polyp according to 2D ultrasonography data; premenopausal age; the absence of clinical manifestations of the endometrial hyperplasia and endometrial polyp; normal size of uterus according to 2D ultrasonography data; the absence of accompanying diffuse and local pathology of myometrium (uterine fibroids, adenomyosis); the absence of ovarian neoplasms according to 2D ultrasonography data (cysts, cystomas); the absence of sharp or exacerbation of chronic inflammatory diseases of genitals; the absence of oncological diseases of any localization; the absence of exacerbation of chronic extragenital pathology.
Exclusion criteria were: reproductive and postmenopausal ages; the presence of vaginal bleeding during hospitalization; the size of the uterus more than normative parameters of premenopausal age; the presence of accompanying diffuse and local pathology of myometrium (uterine fibroids, adenomyosis); the presence of ovarian neoplasms according to 2D ultrasonography data (cysts, cystomas); the presence of sharp or exacerbation of chronic inflammatory diseases of genitals; the presence of oncological diseases of any localization; the presence of exacerbation of chronic extragenital pathology